RoryShallisMD

PubMed

• 13 citations
  Immune checkpoint inhibition in myeloid malignancies: Moving beyond the PD-1/PD-L1 and CTLA-4 pathways.
  Jan Philipp Bewersdorf, Rory M. Shallis, Amer M. Zeidan> ;Blood Reviews. 2021 Jan 1
• 18 citations
  Myeloid sarcoma, chloroma, or extramedullary acute myeloid leukemia tumor: A tale of misnomers, controversy and the unresolved
  Rory M. Shallis, Robert Peter Gale, Hillard M. Lazarus, Kenneth B. Roberts, Mina L. Xu, Stuart Seropian, Steven D. Gore, Nikolai A. Podoltsev> ;Blood Reviews. 2021 May 1
• 1 citations
  Challenging the concept of de novo acute myeloid leukemia: Environmental and occupational leukemogens hiding in our midst.
  Rory M. Shallis, Julian J Weiss, Nicole C. Deziel, Steven D. Gore> ;Blood Reviews. 2021 May 1
• 10 citations
  The minimal that kills: Why defining and targeting measurable residual disease is the "Sine Qua Non" for further progress in management of acute myeloid leukemia.
  Jan Philipp Bewersdorf, Rory M. Shallis, Prajwal C. Boddu, Brent L. Wood, Jerald P. Radich, Stephanie Halene, Amer M. Zeidan> ;Blood Reviews. 2020 Sep 1
• 40 citations
  Special considerations in the management of adult patients with acute leukaemias and myeloid neoplasms in the COVID-19 era: recommendations from a panel of internation...
  Amer M. Zeidan, Prajwal C. Boddu, Mrinal M. Patnaik, Jan Philipp Bewersdorf, Maximilian Stahl, Raajit K. Rampal, Rory M. Shallis, David P. Steensma, Michael R. Savona,...> ;The Lancet Haematology. 2020 Aug 1
• 30 citations
  Clinical outcomes of older patients with AML receiving hypomethylating agents: a large population-based study in the United States.
  Amer M. Zeidan, Rong Wang, Xiaoyi Wang, Rory M. Shallis, Nikolai A. Podoltsev, Jan Philipp Bewersdorf, Scott F. Huntington, Natalia Neparidze, Smith Giri, Steven D. Go...> ;Blood Advances. 2020 May 26
• 27 citations
  Epidemiology of the classical myeloproliferative neoplasms: The four corners of an expansive and complex map
  Rory M. Shallis, Rong Wang, Amy J. Davidoff, Xiaomei Ma, Nikolai A. Podoltsev, Amer M. Zeidan> ;Blood Reviews. 2020 May 22
• 5 citations
  Clinical outcomes and characteristics of patients with TP53-mutated acute myeloid leukemia or myelodysplastic syndromes: a single center experience.
  Jan Philipp Bewersdorf, Rory M. Shallis, Lohith Gowda, Wei Wei, Karl Hager, Iris Isufi, Tae Kon Kim, Manoj M. Pillai, Stuart Seropian, Nikolai A. Podoltsev, Steven D. ...> ;Leukemia & Lymphoma. 2020 May 2
• 13 citations
  Patterns of care and clinical outcomes with cytarabine-anthracycline induction chemotherapy for AML patients in the United States.
  Amer M. Zeidan, Nikolai A. Podoltsev, Xiaoyi Wang, Chi Zhang, Jan Philipp Bewersdorf, Rory M. Shallis, Scott F. Huntington, Natalia Neparidze, Smith Giri, Steven D. Go...> ;Blood Advances. 2020 Apr 28
• 1 citations
  Isolated trisomy 11 in patients with acute myeloid leukemia - is the prognosis not as grim as previously thought?
  Jan Philipp Bewersdorf, Rory M. Shallis, Autumn DiAdamo, Lohith Gowda, Nikolai A. Podoltsev, Alexa J. Siddon, Amer M. Zeidan> ;Leukemia & Lymphoma. 2020 Apr 26
• 7 citations
  Leukocytapheresis for patients with acute myeloid leukemia presenting with hyperleukocytosis and leukostasis: a contemporary appraisal of outcomes and benefits.
  Rory M. Shallis, Maximilian Stahl, Jan Philipp Bewersdorf, Jeanne E. Hendrickson, Amer M. Zeidan> ;Expert Review of Hematology. 2020 Apr 17
• 1 citations
  Cui bono? Finding the value of allogeneic stem cell transplantation for lower-risk myelodysplastic syndromes
  Rory M. Shallis, Nikolai A. Podoltsev, Lohith Gowda, Amer M. Zeidan, Steven D. Gore> ;Expert Review of Hematology. 2020 Mar 29
• 5 citations
  Real-World Outcomes of Adult B-Cell Acute Lymphocytic Leukemia Patients Treated With Inotuzumab Ozogamicin.
  Talha Badar, Aniko Szabo, Martha Wadleigh, Michaela Liedtke, Shukaib Arslan, Caitlin Siebenaller, Ibrahim Aldoss, Elizabeth Schultz, Mehrdad Hefazi, Mark R. Litzow, Er...> ;Clinical Lymphoma, Myeloma & Leukemia. 2019 Nov 13
• 23 citations
  Management of hyperleukocytosis and impact of leukapheresis among patients with acute myeloid leukemia (AML) on short- and long-term clinical outcomes: a large, retros...
  Maximilian Stahl, Rory M. Shallis, Wei Wei, Pau Montesinos, Etienne Lengliné, Judith Neukirchen, Vijaya Raj Bhatt, Mikkael A. Sekeres, Amir T. Fathi, Heiko Konig, Seli...> ;Leukemia. 2020 Mar 4
• 10 citations
  The golden age for patients in their golden years: The progressive upheaval of age and the treatment of newly-diagnosed acute myeloid leukemia.
  Rory M. Shallis, Prajwal C. Boddu, Jan Philipp Bewersdorf, Amer M. Zeidan> ;Blood Reviews. 2020 Mar 1
• 9 citations
  Patterns of care and clinical outcomes of patients with newly diagnosed acute myeloid leukemia presenting with hyperleukocytosis who do not receive intensive chemotherapy
  Rory M. Shallis, Maximilian Stahl, Wei Wei, Pau Montesinos, Etienne Lengliné, Judith Neukirchen, Vijaya Raj Bhatt, Mikkael A. Sekeres, Amir T. Fathi, Heiko Konig, Seli...> ;Leukemia & Lymphoma. 2020 Feb 26
• 1 citations
  Disseminated, yet dissembled: Rare infections behind the veil of classical hairy cell leukemia
  Rory M. Shallis, Timil Patel, Nikolai A. Podoltsev, Mina L. Xu, Marwan M. Azar, Steven D. Gore> ;Leukemia Research. 2020 Jan 31
• 17 citations
  Temporal patterns and predictors of receiving no active treatment among older patients with acute myeloid leukemia in the United States: A population-level analysis.
  Amer M. Zeidan, Nikolai A. Podoltsev, Xiaoyi Wang, Jan Philipp Bewersdorf, Rory M. Shallis, Scott F. Huntington, Steven D. Gore, Amy J. Davidoff, Xiaomei Ma, Rong Wang> ;Cancer. 2019 Dec 1
• 9 citations
  Real World Outcomes of Adult B-Cell Acute Lymphocytic Leukemia Patients Treated with Blinatumomab
  Talha Badar, Aniko Szabo, Anjali S. Advani, Martha Wadleigh, Shukaib Arslan, Muhammad Ali Khan, Ibrahim Aldoss, Caitlin Siebenaller, Elizabeth Schultz, Mehrdad Hefazi,...> ;Blood Advances. 2019 Nov 13
• 7 citations
  Hedgehog pathway inhibition as a therapeutic target in acute myeloid leukemia.
  Rory M. Shallis, Jan Philipp Bewersdorf, Prajwal C Boddu, Amer M. Zeidan> ;Expert Review of Anticancer Therapy. 2019 Aug 17
• 174 citations
  Epidemiology of acute myeloid leukemia: Recent progress and enduring challenges.
  Rory M. Shallis, Rong Wang, Amy J. Davidoff, Xiaomei Ma, Amer M. Zeidan> ;Blood Reviews. 2019 Jul 1
• 7 citations
  Healthcare expenses for treatment of acute myeloid leukemia.
  Jan Philipp Bewersdorf, Rory M. Shallis, Rong Wang, Scott F. Huntington, Sarah Perreault, Xiaomei Ma, Amer M. Zeidan> ;Expert Review of Hematology. 2019 Jun 13
• 7 citations
  Getting personal with myelodysplastic syndromes: is now the right time?
  Nora Chokr, Alexander B Pine, Jan Philipp Bewersdorf, Rory M. Shallis, Maximilian Stahl, Amer M. Zeidan> ;Expert Review of Hematology. 2019 Apr 12
• 2 citations
  What is the best pharmacotherapeutic strategy for treating chronic myeloid leukemia in the elderly
  Rory M. Shallis, Nikolai A. Podoltsev> ;Expert Opinion on Pharmacotherapy. 2019 Apr 5
• Allogeneic stem cell transplantation and combination antiretroviral therapy: cautions, complications, and considerations.
  Rory M. Shallis, Shana E. Gleeson, Marwan M. Azar, Maricar Malinis, Mina L. Xu, Stuart Seropian, Lohith Gowda, Amer M. Zeidan> ;Leukemia & Lymphoma. 2019 Apr 3
• Join now to see all

Abstracts/Posters

• Clinical Outcomes of Older Patients (pts) with Acute Myeloid Leukemia (AML) Receiving Hypomethylating Agents (HMAs): A Large Population-Based Study in the United State...
  Rory M Shallis, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Real World Outcomes of Adult B-Cell Acute Lymphocytic Leukemia Patients Treated with Inotuzumab Ozogamicin
  Rory M Shallis, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Incidence and Risk Factors of Second Malignancies Among Medicare Beneficiaries with Newly-Diagnosed Philadelphia Chromosome-Negative Classical Myeloproliferative Neopl...
  Rory M Shallis, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• The Impact of the 2011 European Leukemianet (ELN) Guidelines for Philadelphia Chromosome-Negative Classical Myeloproliferative Neoplasms on Therapeutic Phlebotomy and ...
  Rory M Shallis, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Real World Outcomes of Adult B-Cell Acute Lymphocytic Leukemia Patients Treated with Blinatumomab
  Rory M Shallis, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Patterns of Care and Clinical Outcomes with 7+3 Induction Chemotherapy for Patients (pts) with Acute Myeloid Leukemia (AML) in the United States (US): A Large Populati...
  Rory M Shallis, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Join now to see all

Lectures

• Immune Checkpoint Inhibitor Therapy for Acute Myeloid Leukemia and Higher-Risk Myelodysplastic Syndromes: A Single-Center Experience 
  61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019